References
- Billing K, Karagiannis A, Selva D. Punctal–canalicular stenosis associated with mitomycin-C for corneal epithelial dysplasia. Am J Ophthalmol 2003; 136(4):746–747.
- Esmaeli B, Valero V, Ahmadi MA, Booser D. Canalicular stenosis secondary to docetaxel (Taxotere): a newly recognized side effect. Ophthalmology 2001; 108(5):994–995.
- Caravella LP Jr, Burns JA, Zangmeister M. Punctal–canalicular stenosis related to systemic fluorouracil therapy. Arch Ophthalmol 1981; 99(2):284–286.
- Chua WC, Martin PA, Kourt G. Watery eye: a new side-effect of isotretinoin therapy. Eye 2001; 15(pt 1):115–116.
- Kaiser P. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP Report No. 8. Graefes Arch Clin Exp Ophthalmol 2006; 244(9):1132–1142.
- Azab M, Benchaboune M, Blinder KJ, Bressler NM, Bressler SB, Gragoudas ES, et al. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin in Photodynamic Therapy (VIP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analys is of 2-year safety results in three randomized clinical trials: Treatment of Age-Related Macular Degeneration with Photodynamic Therapy and Verteporfin in Photodynamic Therapy Study Report No. 4.. Retina 2004; 24(1):1–12.